Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
by
Rathakrishnan, Priyadharshini
, Lah, James J.
, Gao, Tianwen
, Dammer, Eric B.
, Raza, Syed Ali
, Xiao, Hailian
, Duong, Duc M.
, Seyfried, Nicholas T.
, Levey, Allan I.
, Rangaraju, Srikant
, Pennington, Michael W.
in
Aging
/ Alzheimer Disease - metabolism
/ Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid
/ Animal models
/ Animals
/ Antigens
/ Apolipoprotein E
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain
/ CD44 antigen
/ Cognitive ability
/ CXCR4 protein
/ Development and progression
/ Drug discovery
/ Flow cytometry
/ Gene expression
/ Genetic aspects
/ Genome-Wide Association Study
/ Genomes
/ Humans
/ Immunoglobulins
/ Immunomodulation
/ Inflammation - metabolism
/ Inflammation - pathology
/ Insulin-like growth factor I
/ Interleukin 1
/ Kv1.3
/ Macrophage
/ Mice
/ Microglia
/ Microglia - metabolism
/ Microglia - pathology
/ Molecular Medicine
/ Network analysis
/ Neurodegeneration
/ Neurology
/ Neurosciences
/ NF-κB protein
/ Pathology
/ Phagocytes
/ Phenotypes
/ Physiological aspects
/ Potassium channel
/ Potassium channels (voltage-gated)
/ RelA protein
/ Research Article
/ Stat1 protein
/ Surface markers
/ Transcription
/ Transcriptome
2018
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
by
Rathakrishnan, Priyadharshini
, Lah, James J.
, Gao, Tianwen
, Dammer, Eric B.
, Raza, Syed Ali
, Xiao, Hailian
, Duong, Duc M.
, Seyfried, Nicholas T.
, Levey, Allan I.
, Rangaraju, Srikant
, Pennington, Michael W.
in
Aging
/ Alzheimer Disease - metabolism
/ Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid
/ Animal models
/ Animals
/ Antigens
/ Apolipoprotein E
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain
/ CD44 antigen
/ Cognitive ability
/ CXCR4 protein
/ Development and progression
/ Drug discovery
/ Flow cytometry
/ Gene expression
/ Genetic aspects
/ Genome-Wide Association Study
/ Genomes
/ Humans
/ Immunoglobulins
/ Immunomodulation
/ Inflammation - metabolism
/ Inflammation - pathology
/ Insulin-like growth factor I
/ Interleukin 1
/ Kv1.3
/ Macrophage
/ Mice
/ Microglia
/ Microglia - metabolism
/ Microglia - pathology
/ Molecular Medicine
/ Network analysis
/ Neurodegeneration
/ Neurology
/ Neurosciences
/ NF-κB protein
/ Pathology
/ Phagocytes
/ Phenotypes
/ Physiological aspects
/ Potassium channel
/ Potassium channels (voltage-gated)
/ RelA protein
/ Research Article
/ Stat1 protein
/ Surface markers
/ Transcription
/ Transcriptome
2018
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
by
Rathakrishnan, Priyadharshini
, Lah, James J.
, Gao, Tianwen
, Dammer, Eric B.
, Raza, Syed Ali
, Xiao, Hailian
, Duong, Duc M.
, Seyfried, Nicholas T.
, Levey, Allan I.
, Rangaraju, Srikant
, Pennington, Michael W.
in
Aging
/ Alzheimer Disease - metabolism
/ Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid
/ Animal models
/ Animals
/ Antigens
/ Apolipoprotein E
/ Bioinformatics
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain
/ CD44 antigen
/ Cognitive ability
/ CXCR4 protein
/ Development and progression
/ Drug discovery
/ Flow cytometry
/ Gene expression
/ Genetic aspects
/ Genome-Wide Association Study
/ Genomes
/ Humans
/ Immunoglobulins
/ Immunomodulation
/ Inflammation - metabolism
/ Inflammation - pathology
/ Insulin-like growth factor I
/ Interleukin 1
/ Kv1.3
/ Macrophage
/ Mice
/ Microglia
/ Microglia - metabolism
/ Microglia - pathology
/ Molecular Medicine
/ Network analysis
/ Neurodegeneration
/ Neurology
/ Neurosciences
/ NF-κB protein
/ Pathology
/ Phagocytes
/ Phenotypes
/ Physiological aspects
/ Potassium channel
/ Potassium channels (voltage-gated)
/ RelA protein
/ Research Article
/ Stat1 protein
/ Surface markers
/ Transcription
/ Transcriptome
2018
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
Journal Article
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
2018
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Disease-associated-microglia (DAM) represent transcriptionally-distinct and neurodegeneration-specific microglial profiles with unclear significance in Alzheimer’s disease (AD). An understanding of heterogeneity within DAM and their key regulators may guide pre-clinical experimentation and drug discovery.
Methods
Weighted co-expression network analysis (WGCNA) was applied to existing microglial transcriptomic datasets from neuroinflammatory and neurodegenerative disease mouse models to identify modules of highly co-expressed genes. These modules were contrasted with known signatures of homeostatic microglia and DAM to reveal novel molecular heterogeneity within DAM. Flow cytometric validation studies were performed to confirm existence of distinct DAM sub-populations in AD mouse models predicted by WGCNA. Gene ontology analyses coupled with bioinformatics approaches revealed drug targets and transcriptional regulators of microglial modules predicted to favorably modulate neuroinflammation in AD. These guided in-vivo and in-vitro studies in mouse models of neuroinflammation and neurodegeneration (5xFAD) to determine whether inhibition of pro-inflammatory gene expression and promotion of amyloid clearance was feasible. We determined the human relevance of these findings by integrating our results with AD genome-wide association studies and human AD and non-disease post-mortem brain proteomes.
Results
WGCNA applied to microglial gene expression data revealed a transcriptomic framework of microglial activation that predicted distinct pro-inflammatory and anti-inflammatory phenotypes within DAM, which we confirmed in AD and aging models by flow cytometry. Pro-inflammatory DAM emerged earlier in mouse models of AD and were characterized by pro-inflammatory genes (Tlr2, Ptgs2, Il12b, Il1b), surface marker CD44, potassium channel Kv1.3 and regulators (NFkb, Stat1, RelA) while anti-inflammatory DAM expressed phagocytic genes (Igf1, Apoe, Myo1e), surface marker CXCR4 with distinct regulators (LXRα/β, Atf1). As neuro-immunomodulatory strategies, we validated LXRα/β agonism and Kv1.3 blockade by ShK-223 peptide that promoted anti-inflammatory DAM, inhibited pro-inflammatory DAM and augmented Aβ clearance in AD models. Human AD-risk genes were highly represented within homeostatic microglia suggesting causal roles for early microglial dysregulation in AD. Pro-inflammatory DAM proteins were positively associated with neuropathology and preceded cognitive decline confirming the therapeutic relevance of inhibiting pro-inflammatory DAM in AD.
Conclusions
We provide a predictive transcriptomic framework of microglial activation in neurodegeneration that can guide pre-clinical studies to characterize and therapeutically modulate neuroinflammation in AD.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
This website uses cookies to ensure you get the best experience on our website.